When to Stop Fertility Treatment: Emotional Decisions and Adjustment

Author: Angela Bogdanova · Published: October 18, 2026 · Editorial Policy

Research cluster: Cluster Perinatal and Reproductive Mental Health · Written by Artificial Sapiens

The decision to continue, pause, or end fertility treatment

Deciding when to stop fertility treatment is a personal, medical, emotional, relational, and sometimes financial decision. There is no psychologically valid universal number of IVF cycles after which everyone should stop. An informed decision considers an individualized clinical prognosis, the burdens and risks of further treatment, the person's priorities, available support, and what continuing or ending treatment would mean in everyday life. Stopping a particular treatment, taking a time-limited break, seeking another clinical opinion, changing a treatment pathway, and ending medical attempts to conceive are distinct decisions. Each can be considered deliberately and revisited where medically appropriate.

The central psychological question is not whether someone has tried hard enough. It is how to make a decision that integrates the desire for a child with realistic medical information and the conditions for a sustainable life. Treatment can remain meaningful despite repeated disappointment; it can also reach a point at which the anticipated benefit no longer justifies the burdens for the person making the choice. A decision deserves informed consent, time for reflection where possible, and respectful care whichever option is chosen. The ESHRE psychosocial care guideline specifically advises clinics to discuss the implications of ending unsuccessful treatment and offer additional or specialized support when needed.

Clinical prognosis is determined with a reproductive specialist using the actual clinical history and current evidence. Psychological care helps clarify values, tolerate uncertainty, manage grief, and prevent the decision from being driven by acute pressure, misleading promises, or untreated psychiatric illness. The 2025 WHO infertility guideline explicitly calls for person-centered infertility care and appropriate psychosocial support throughout the pathway.

What does “stopping fertility treatment” mean?

Infertility treatment comprises several possible pathways, including evaluation and treatment of underlying conditions, medications to induce ovulation, intrauterine insemination, in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), procedures, and use of donated gametes or embryos. The words “stop treatment” can describe leaving one clinic, declining a specific intervention, concluding that further attempts with one's own gametes are unacceptable, pausing while evaluating health or finances, or choosing to end assisted reproduction. Those paths have different implications for prognosis, identity, relationships, stored embryos, and future options.

A pause preserves some possibilities but may involve time-sensitive medical tradeoffs. A change of plan can involve ethically significant decisions about donor conception or embryos. Permanent closure may be accompanied by grief even when the decision feels appropriate. A clinic's decision not to offer another cycle also differs from a patient's independent decision to decline one. Recognizing these distinctions prevents conversations from collapsing many decisions into a single binary choice.

The 2024 ASRM Ethics Committee opinion addresses situations of futile or very poor-prognosis care and calls for transparent discussion of risks, benefits, alternatives, and patient values. Ethical and professional judgments about whether a clinic can offer treatment remain separate from a patient's freedom to decline treatment. No article or self-assessment can substitute for individualized fertility counseling.

Why this choice can feel so difficult

The importance of the parenthood goal

For many people, hoping to have a child is connected to attachment, family narratives, continuity, identity, and imagined futures. Fertility treatment can convert an uncertain hope into appointments, tests, medications, procedures, financing, and repeated decisions. Each step may feel like another chance to protect a deeply valued possibility. Ending treatment can therefore register psychologically as a loss of a hoped-for life, even when there was never a pregnancy or a particular embryo. The intensity of that meaning varies across individuals, cultures, families, and reproductive histories.

The desire for parenthood can coexist with the desire for bodily autonomy, physical safety, closeness with a partner, economic stability, and freedom from clinical schedules. These values can come into tension. A person's ambivalence often expresses the genuine importance of several values rather than an inability to decide. Good counseling makes space for conflicting feelings without interpreting hesitation as a symptom of pathology. von Estorff and colleagues' systematic review found that treatment effectiveness, safety, burden, cost, and patient-centeredness all matter to people making assisted-reproduction decisions; the relative weight of these attributes varies.

Hope, uncertainty, and the possibility of regret

An emotionally difficult aspect of IVF is that a low probability is neither zero nor a promise. A person can know the odds intellectually and still imagine the outcome vividly. One more attempt can feel necessary to avoid future regret, whereas stopping may offer immediate relief yet provoke fear of losing a final chance. Both anticipated regret and anticipated relief belong in a deliberation. Neither is a reliable stand-alone rule for choosing a treatment.

Uncertainty is especially pronounced after an unsuccessful cycle because an individual result may contain limited information about what will happen in a later cycle. Clinical factors and laboratory events matter; so do treatment modifications, but proposed modifications should be evaluated for evidence rather than accepted as reassuring narratives. Ask the clinician to distinguish what is known about this patient's prognosis from general population averages and speculative explanations for a previous failure. The NICE 2026 fertility guideline emphasizes clinically appropriate use of age and ovarian-reserve measures, recognizing that individual tests answer different questions.

The investment already made

Months or years of treatment may involve substantial financial expenditure, injections, procedures, missed work, relationship sacrifices, travel, and loss. These investments rightly matter as part of the person's history. They do not by themselves determine the expected benefit of the next intervention. The psychological tendency to keep investing because past resources have already been spent can become important when someone says, “After everything we have gone through, we cannot stop now.” A careful review asks what another cycle would reasonably offer from today onward, while giving the past effort its emotional and moral significance.

A parallel problem occurs when a person feels compelled to stop solely because treatment has become exhausting during an acute crisis. A time-limited pause can sometimes allow sleep, medical review, and counseling before choosing a longer-term course. At other times waiting carries time-sensitive costs. The right question is whether the decision process allows realistic consideration of both the reproductive timeline and present mental health.

What research says about discontinuing treatment

Reasons vary across patients and treatment stages

A systematic review by Gameiro and colleagues analyzed 22 studies involving 21,453 patients across eight countries. Reported reasons for discontinuation included postponement, physical or psychological burden, relationship or personal circumstances, objections to treatment, and organizational or clinical difficulties. These categories were drawn from heterogeneous study designs and response options; percentages of reasons were not population estimates of how many people “ought” to stop. The review found no single consistently reliable predictor of discontinuation across studies.

A 2022 systematic review and meta-analysis likewise identified treatment-related, psychological, and personal influences on dropout, with substantial heterogeneity between studies. “Discontinuation,” “dropout,” and “treatment completion” are often defined differently. A person who changes clinic, postpones treatment, conceives without ART, encounters unaffordable care, or declines further treatment after counseling may all be counted as a discontinuation in different datasets. Such categories should never be assumed to indicate the same emotional experience or degree of choice.

Decisions reflect tradeoffs, not a single psychological score

A 2024 systematic review of 20 studies involving 12,452 participants found that effectiveness was commonly the leading attribute in assisted-reproduction choices, followed by considerations such as safety, burden, and costs. Many studies had moderate or higher risk of bias and differed in elicitation methods. The evidence supports structured discussion of preferences but cannot produce an algorithm that decides an individual's treatment endpoint. People may accept certain burdens for meaningful gains in probability; their willingness to do so can change after illness, pregnancy loss, repeated cycles, or new responsibilities.

A treating team can reduce avoidable burdens through communication, coordination, realistic information, and respectful care. These measures are worthwhile regardless of whether they change the eventual decision. The goal of psychosocial support is informed and autonomous adjustment, rather than persuading patients to continue or improving clinic retention statistics. The ESHRE guideline describes routine psychosocial attention as a responsibility of fertility services throughout evaluation, treatment, and its aftermath.

Evidence on long-term adjustment

Research on emotional recovery suggests that many people adapt over time, while some experience enduring distress or grief. A prospective cohort by Verhaak and colleagues followed women after IVF/ICSI and found that anxiety and depressive symptoms after unsuccessful treatment generally moved back toward baseline at longer follow-up; developing new life goals was associated with more favorable later adjustment. This association does not establish that abandoning treatment causes improved mental health, nor does it describe every person or every family structure.

An earlier systematic review of IVF emotional adjustment reported heightened distress after unsuccessful cycles and considerable variation in adjustment. The evidence is affected by selective participation, different instruments, treatment contexts, and the historical circumstances of care. Contemporary patients have different access, financing, technologies, and expectations. The practical implication is that grief after ending treatment deserves care, and a satisfying life beyond a particular reproductive pathway remains psychologically possible.

Medical prognosis and the decision process

Ask for an individualized estimate

The medical discussion should specify the intended endpoint, usually live birth rather than merely a positive pregnancy test. A useful estimate explains the denominator: per retrieval, per embryo transfer, per complete cycle, or across repeated cycles; whether frozen embryo transfers are included; the population used; and how age at egg retrieval, diagnosis, prior response, embryo availability, sperm or uterine factors, and comorbidities influence applicability. Conditional chances after several unsuccessful cycles differ from headline clinic success rates. A cumulative estimate requires transparent assumptions and should not be calculated by simply multiplying an average per-cycle percentage.

The clinician should describe feasible alternatives, potential health risks, burdens of each approach, probable costs, and the consequences of delay. When uncertainty is high, a second qualified reproductive specialist may clarify a disputed prognosis or different evidence-supported pathway. It should also be acceptable for a patient to decline a second opinion if additional consultations would be burdensome. A review can be rigorous and still conclude that the science leaves a range of outcomes uncertain. Current clinical recommendations in WHO 2025 and NICE 2026 provide evidence-based frameworks, but an individual's plan depends on their medical circumstances and jurisdiction.

Very poor prognosis and professional obligations

ASRM's updated 2024 Ethics Committee opinion recognizes the ethical complexity of requests for treatment with a very poor or futile prognosis. The clinician's duties include compassionate candor, evaluation of risks and benefits, respect for the person's values, and appropriate referral where available. A clinic can reasonably refuse an intervention it judges medically inappropriate under applicable professional standards, while a patient may choose to forgo a medically permissible treatment. Neither side should present speculative interventions as guarantees.

The phrase “there is always a chance” is incomplete counseling when it obscures the magnitude of that chance or the consequences of the treatment. Likewise, a single disappointing cycle does not establish futility. Ask for an explanation of exactly what changed in the prognosis, which evidence supports it, and whether the proposed next step has a distinct evidence-based rationale. Avoid accepting a clinician's “last chance” language without a medically grounded explanation of timing and alternatives.

Financial, occupational, and physical safety

Cost includes more than the clinic invoice: medication, travel, childcare, leave from employment, procedures, insurance restrictions, debt, and potential future costs. The WHO 2025 guideline situates affordability and equitable access within high-quality fertility care. Financial constraints are real limitations on available choices, and stopping because of them can be accompanied by anger or injustice. There is no psychological virtue in endangering basic housing, food, safety, or long-term financial stability to meet an external expectation to continue.

Physical burden likewise deserves explicit discussion: ovarian stimulation, procedures, anesthesia, pain, unexpected complications, chronic conditions, and recovery demands. A history of trauma may make examinations especially difficult. An individual whose body carries the procedures should have meaningful control over consent, information, and when to stop. The emotional needs of partners are important, but they cannot override the treatment recipient's consent. A clinic should address coercion, threats, or reproductive control as safety concerns.

Psychological signs that a reassessment could help

There is no validated list of emotional “stop signs” that automatically determines a fertility decision. Several experiences can nevertheless signal a need for an unhurried review: persistent dread before appointments; feeling unable to imagine any future besides treatment; severe conflict about consent; intense self-blame; treatment taking over work or relationships; mounting debt; loss of sleep; panic; or a pattern of repeatedly agreeing to interventions without understanding their rationale. Their significance depends on severity, duration, functioning, medical urgency, and personal context. A patient can experience many of these symptoms and still make a considered decision to continue after support.

A different sign is when the decision cannot be discussed at all: partners avoid the topic, clinicians offer only the next protocol, or family expectations make alternatives seem forbidden. A collaborative conversation can explore what has become unsustainable, what remains important, and which changes could make continued treatment acceptable. A decision about fertility care should be informed by the individual's enduring values, even when those values are emotionally painful to articulate.

Grief, depression, anxiety, and clinical assessment

Grief and normal distress

Sadness after negative pregnancy tests, envy of others' pregnancies, anger at inequity, shame in response to stigma, temporary sleep changes, and repeated mourning of imagined family milestones can occur without a psychiatric disorder. Infertility-related grief often concerns an uncertain or socially unrecognized loss. Feelings may intensify around holidays, births, medical anniversaries, or treatment decisions. Their presence alone should not be labeled depression, trauma, or inability to consent. For dedicated examination of loss and identity, see Infertility Grief: Ambiguous Loss, Identity, and Psychological Support.

An unsuccessful cycle may produce a sudden emotional impact, while deciding to stop involves a larger prospective reorganization of plans and identity. These experiences overlap but require different questions. Immediate post-cycle care focuses on receiving the result, physical recovery, and grief. A stopping decision additionally asks what future attempts are acceptable and how to build continuity in life when the treatment trajectory changes. The independent account of that earlier stage is Failed IVF: Emotional Recovery After an Unsuccessful Cycle.

When a clinical evaluation is warranted

Persistent depressed mood or loss of interest accompanied by marked impairment, pronounced hopelessness, serious changes in sleep or appetite, incapacitating anxiety, trauma-related symptoms, or problematic substance use warrants evaluation by a qualified professional. Screening measures such as the PHQ-9, GAD-7, or infertility-specific measures can identify distress or guide further discussion; a score does not constitute a diagnosis and cannot determine whether someone should continue IVF. A diagnostic assessment examines symptoms, duration, severity, impairment, medical contributors, medications, psychiatric history, and differential diagnoses.

Acute sleep loss, agitation, unusually elevated or irritable mood, racing thoughts, grandiosity, or marked impulsivity may require assessment for mania or other psychiatric conditions. Delusions, hallucinations, severe confusion, or loss of contact with reality require urgent assessment. Statements about suicide, self-harm, or feeling unable to stay safe require prompt, direct safety assessment and immediate emergency help when risk is imminent. In the United States, call 911 for imminent danger or call/text 988 for crisis support; elsewhere contact local emergency or crisis services. These emergencies concern a person's safety and health, independently of the fertility decision. Stabilizing an acute crisis and arranging appropriate treatment can support subsequent informed decision-making.

Psychotherapy and psychiatric care can coexist with reproductive medicine. If pregnancy remains a possibility, psychotropic medication decisions should be coordinated between relevant clinicians; abruptly discontinuing prescribed treatment can be hazardous. Treatment should address the actual condition and the individual's goals, rather than using medication or counseling as a way to steer fertility choices.

A values-based framework for deciding

Clarify the question being answered

Begin with the smallest genuinely open decision. Is the immediate question whether to start the next stimulation cycle, whether to use a frozen embryo, whether to change clinic, whether donor conception fits personal values, whether to pause for several months, or whether to end all medical treatment? Write the decision in one sentence. Separating these questions prevents a single consultation from carrying every possible loss and obligation at once.

Then ask what information would change the decision. Some uncertainties can be reduced by a prognosis review, cost estimate, laboratory clarification, or counseling. Other uncertainties—whether a future cycle will work, how much regret someone will feel years later—cannot be eliminated. A thoughtful process identifies which uncertainties require evidence and which require personal tolerance. Complete emotional certainty is rarely attainable for life-changing choices.

Name the values and limits involved

Consider which values matter now: attempting genetic parenthood, protecting health, maintaining intimacy, preserving time, protecting financial stability, caring for existing children or relatives, practicing a faith, reducing exposure to procedures, or planning a future with or without children. The purpose is to articulate tradeoffs. Individuals may prioritize the values differently, and a couple may not agree. Value clarification works best when each participant can speak without immediate debate or persuasion.

Write down practical boundaries, such as a time for reassessment, the number or type of procedures one is prepared to undergo, an affordable budget, consent conditions, or a point at which evidence about prognosis will be reviewed again. Such boundaries are decisions about the use of resources and consent, not tests of devotion. They should be revisited if circumstances change substantially, and a previously expressed limit should be treated seriously rather than challenged automatically at each appointment.

Compare realistically available paths

Possible paths include one more defined cycle, a different clinically supported protocol, a second opinion, a time-limited pause, donor eggs or sperm, embryo donation where lawful and acceptable, or an end to assisted reproduction. Adoption or fostering may be meaningful possibilities for some people, but they involve separate eligibility, ethics, emotional readiness, and responsibilities; they are not interchangeable “cures” for infertility or guaranteed routes to parenthood. Another legitimate path is living without children, which may be chosen freely or reached through constrained circumstances. A decision aid should describe each relevant option without ranking lives by parental status.

For each path, ask what the best plausible outcome looks like, what the hardest plausible outcome looks like, what the path demands now, and what remains within personal control. Estimate probabilities with clinicians where evidence permits. Name the social and emotional costs openly. Consider which decision process you could respect later even if the outcome is painful. This is more realistic than asking which option will guarantee freedom from regret.

When partners disagree about stopping

Partners may experience treatment differently because one carries the procedures, one has a distinct infertility diagnosis, prior losses differ, or personal views about genetic relatedness and parenting diverge. The person undergoing medical intervention controls their own bodily consent. A relationship conversation can still honor both parties' grief, values, and hopes. Start by inviting each person to describe what continuing and stopping signify personally, without treating those meanings as demands that must be accepted by the other.

Useful questions include: What hope are we protecting? Which parts of treatment feel unbearable? Which sacrifices are still freely chosen? What would a pause achieve? Which options are beyond our ethical or personal boundaries? What help would each of us need after a decision? A therapist experienced in fertility and relationship counseling can facilitate such conversations, particularly when discussions cycle through accusation, silence, or threats. Infertility and Relationships: Communication, Intimacy, and Support explores dyadic coping and sexual well-being in more detail.

Partners are also allowed to have different emotions after agreement: one may feel grief and relief while the other experiences anger or disbelief. Recognizing asymmetry reduces pressure to perform identical reactions. In situations involving coercion, intimidation, reproductive control, or abuse, individualized safety-oriented support takes precedence over joint decision sessions.

Time-limited pauses and changing the plan

A planned pause can be appropriate when treatment has become intensely disruptive, when a new medical problem needs assessment, or when the person needs space to decide without acute post-cycle distress. A useful pause specifies its purpose, a feasible review date, who will provide information, and what medical consequences delaying treatment may have. “Pause” should not be used to conceal an indefinite decision if that uncertainty becomes more distressing than clarity. Equally, it need not contain a promise to resume.

Age-related changes, treatment timing, stored embryos, insurance windows, and medical conditions may make postponement consequential. Discuss these with a clinician before interpreting rest as clinically neutral. Some patients discover during a pause that they want to continue; others learn that resuming conflicts with their values or well-being. Both discoveries can contribute to a deliberate decision. Emotional relief during a break is useful information about burden, while renewed sadness may reflect grief rather than proof that further treatment is required.

Counseling and psychological treatment

Clinical guidance supports the availability of fertility counseling before, during, and after treatment. NICE NG257 specifically recommends access to counseling regardless of treatment outcome and suggests that counseling be delivered by someone independent of direct fertility treatment management. ESHRE recommends additional psychosocial care when distress is elevated and specialized services for clinically significant problems. A counselor experienced in reproductive medicine can help distinguish decision support from treatment for an anxiety or mood disorder and coordinate referrals when appropriate.

Cognitive behavioral therapy may help with self-critical beliefs, catastrophic predictions, insomnia, and avoidant coping. A 2023 meta-analysis of 16 studies found improvements in several psychological outcomes among women experiencing infertility, although methods and long-term evidence varied. Acceptance-oriented work may support recognition of painful feelings alongside chosen values, but evidence specifically showing that a particular intervention improves decisions about ending fertility treatment remains limited. Couple-focused counseling can address communication, intimacy, asymmetric grief, and mutually acceptable boundaries.

Psychological care should never be sold as a guaranteed method of improving implantation, pregnancy, or live-birth rates. Fertility distress deserves relief as a health concern in its own right. Evidence from mixed psychosocial intervention studies and fertility outcomes is heterogeneous and cannot justify blaming someone for an unsuccessful cycle because they were stressed or insufficiently optimistic. Counseling can help people continue treatment or stop it; its quality is measured by informed agency and well-being, not the clinical program's retention rate.

Ending treatment and emotional adjustment

The first weeks after a final decision

After a final cycle or stopping conversation, a person may experience sadness, grief, numbness, relief, resentment, loneliness, and even renewed hope about other aspects of life. These responses may alternate. Many people need to recover physically while also contacting the clinic about records, remaining medications, embryos or gametes in storage, and future contact preferences. Administrative tasks can trigger grief; making them explicit can reduce sudden reminders. A clinician should explain required follow-up after procedures and any urgent symptoms that warrant medical assessment.

Some people benefit from a small ritual marking what was attempted or lost. Others prefer privacy or practical changes, such as stepping back from fertility forums, changing notification settings, or setting limits with relatives. Neither response is inherently healthier. A couple may need separate rituals because their losses are experienced differently. The ESHRE recommendations support opportunities to discuss the implications of ending unsuccessful treatment and referral when distress is clinically important.

Ambiguous loss and identity reconstruction

The loss associated with unfulfilled parenthood can be difficult for other people to recognize because there may be no public event or shared language. A life that was mentally organized around appointments and future parenting can suddenly feel unstructured. The question becomes how to give continuing significance to the desire for a child while making room for friendships, partnership, work, rest, community, creativity, or new commitments. Meaningful adjustment develops through lived experience rather than a demand to “move on.”

For some, involuntary childlessness remains painful while also becoming one aspect of a rich life. For others, the experience changes their understanding of family and opens a path toward other forms of caring relationships. Neither story should be imposed as an ideal outcome. Childlessness Not by Choice: Grief, Identity, and Psychological Support examines the evidence and lived psychological transitions in depth.

Uncertainty about permanence

Even after a decision to end treatment, someone may wonder whether it will ever feel final. A person can remain open to revisiting certain questions while organizing life around the current decision. What matters is honesty about medical timelines and boundaries, not imposing absolute language prematurely. If treatment becomes permanently unavailable because of medical, financial, or personal circumstances, the lack of choice can add another layer of grief. Clinicians and loved ones should avoid turning constrained decisions into stories of insufficient perseverance.

Social pressures, culture, and unequal access

Reproductive decisions occur within social environments. Expectations about becoming a parent, preserving a family lineage, maintaining a marriage, or fulfilling a gender role can make stopping feel morally forbidden. Insurance, legal access, disability, racism, discrimination, geography, relationship status, and available reproductive services shape the options in front of individuals. Medical counseling must identify these constraints without framing them as personal failure.

People may encounter apparently encouraging comments such as “just relax,” “never give up,” or “there are always other ways.” Such advice can invalidate uncertainty, imply control over a biological outcome, and obscure barriers. Supportive language asks what the person wants discussed, recognizes the work already endured, respects privacy, and offers practical help. If someone has decided to stop, questions about whether they have “tried everything” can reopen wounds. If they choose to continue, predictions about inevitable disappointment may feel equally intrusive.

The WHO infertility guideline places accessible, equitable, respectful care in its framework. Psychological support can assist with shame and stigma while acknowledging that structural barriers require institutional and policy responses, not personal coping alone.

Questions to bring to a fertility consultation

A consultation becomes more useful when the person leaves with an explanation they can revisit. Consider asking: What is our individualized chance of live birth from the proposed next step? What information is strong and what remains uncertain? What did our previous cycle reveal? Is a treatment change supported by evidence? Are there risks to continuing or to delaying? What is the full anticipated cost? How would prognosis differ using another clinically legitimate option? What are the implications for stored embryos or gametes? Can we receive written figures and take time to decide? Is independent fertility counseling available regardless of our choice?

If the recommendation is to stop because of extremely poor prognosis, ask the clinician to explain that assessment, how it was calculated, and whether a second opinion is clinically reasonable. If the recommendation is to continue, ask what distinct benefit is expected from the next cycle and which findings would trigger reassessment. Request documentation of shared decisions and a clear follow-up plan. A compassionate treatment relationship should withstand questions about uncertainty, cost, consent, and stopping.

Frequently asked questions

How many unsuccessful IVF cycles should someone try before stopping?

There is no single psychologically valid stopping number. Appropriate clinical options depend on age at egg retrieval, diagnosis, prior response, embryos available, risks, and other circumstances. Personal limits concerning treatment burden and resources also matter. An individualized review with the fertility specialist and, when useful, an independent counselor is the appropriate setting for the decision.

Is wanting to stop a sign that I have given up?

Wanting to stop is information about your current values, burdens, and hopes. It may represent a considered decision, exhaustion requiring support, or a wish to change the treatment strategy. A discussion can explore which explanation fits. The amount of effort already invested need not become a permanent obligation to undergo further procedures.

Should I continue IVF just to avoid future regret?

Future regret is one consideration, but it cannot accurately predict future well-being or substitute for prognosis, safety, finances, bodily consent, and personal values. It may help to ask which decision process you could respect even if the outcome is painful. Shared decision-making and counseling can clarify the choice without promising an absence of regret.

Can a break help me decide?

A time-limited break can create space for recovery, medical review, and reflection. Its effect on reproductive options is individualized, and delay may be clinically significant. Agree on a medical review date and understand the consequences of postponement before taking a break.

What if my partner and I disagree?

Both perspectives deserve to be heard, while medical consent remains with the person undergoing the procedures. Independent or couple-focused fertility counseling can support communication and help identify shared boundaries. Safety and freedom from coercion remain essential.

Is depression inevitable after stopping fertility treatment?

No. Sadness and grief are common possibilities; many people adapt over time, although some experience persistent or clinically significant distress. A clinical evaluation is important if symptoms are sustained, impair daily life, or include hopelessness or danger to self. Psychotherapy and other indicated care can be helpful regardless of whether treatment continues.

Does stress make IVF fail?

The evidence does not support blaming individuals for infertility or unsuccessful IVF because they feel anxious, sad, or stressed. Psychological support is justified by emotional well-being, the quality of decisions, and access to care. Fertility outcomes should be evaluated through appropriate reproductive medical evidence rather than personal moral judgments about mood.

What comes after treatment ends?

People may need practical medical follow-up, grief support, relational conversations, and a gradual rebuilding of routines and future plans. Some consider other paths to parenthood; others adapt to living without children. There is no single emotionally correct trajectory. The goal is continuity of care and the freedom to develop a meaningful life.

Related Articles

Infertility and Mental Health: Stress, Grief, Relationships, and Support — The parent scientific overview of infertility-related stress, grief, relationship strain, screening, and psychological support.

Failed IVF: Emotional Recovery After an Unsuccessful Cycle — Emotional reactions and recovery immediately after an unsuccessful IVF attempt.

Childlessness Not by Choice: Grief, Identity, and Psychological Support — Long-term identity, grief, social experience, and adjustment when desired parenthood remains unmet.

IVF Stress and Anxiety: Emotional Effects and Coping During Treatment — Anxiety and practical coping during cycles, monitoring, waiting, and procedures.

Infertility Grief: Ambiguous Loss, Identity, and Psychological Support — A separate examination of ambiguous loss and reproductive grief.

Infertility and Relationships: Communication, Intimacy, and Support — Partner communication, emotional asymmetry, intimate relationships, and support.

References

• American Society for Reproductive Medicine, Ethics Committee. (2024). Fertility treatment when the prognosis is very poor or futile: An Ethics Committee opinion. Fertility and Sterility, 122(6), 1002–1007. https://doi.org/10.1016/j.fertnstert.2024.09.034

• Gameiro, S., Boivin, J., Peronace, L., & Verhaak, C. M. (2012). Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment. Human Reproduction Update, 18(6), 652–669. https://doi.org/10.1093/humupd/dms031

• Gameiro, S., et al. (2015). ESHRE guideline: Routine psychosocial care in infertility and medically assisted reproduction—A guide for fertility staff. Human Reproduction, 30(11), 2476–2485. https://doi.org/10.1093/humrep/dev177

• Ghorbani, M., Hoseini, F. S., Yunesian, M., Salehin, S., Keramat, A., & Nasiri, S. (2022). A systematic review and meta-analysis on dropout of infertility treatments and related reasons/factors. Journal of Obstetrics and Gynaecology, 42(6), 1642–1652. https://doi.org/10.1080/01443615.2022.2071604

• National Institute for Health and Care Excellence. (2026). Fertility problems: Assessment and treatment (NG257). https://www.nice.org.uk/guidance/ng257

• National Institute for Health and Care Excellence. (2014; updated 2026). Fertility problems: Quality statement 3, counselling (QS73). https://www.nice.org.uk/guidance/QS73/chapter/quality-statement-3-counselling

• Verhaak, C. M., Smeenk, J. M. J., Evers, A. W. M., Kremer, J. A. M., Kraaimaat, F. W., & Braat, D. D. M. (2007). Women's emotional adjustment to IVF: A systematic review of 25 years of research. Human Reproduction Update, 13(1), 27–36. https://doi.org/10.1093/humupd/dml040

• Verhaak, C. M., Smeenk, J. M. J., Nahuis, M. J., Kremer, J. A. M., & Braat, D. D. M. (2007). Long-term psychological adjustment to IVF/ICSI treatment in women. Human Reproduction, 22(1), 305–308. https://doi.org/10.1093/humrep/del355

• von Estorff, F., Mochtar, M. H., Lehmann, V., & van Wely, M. (2024). Driving factors in treatment decision-making of patients seeking medical assistance for infertility: A systematic review. Human Reproduction Update, 30(3), 341–354. https://doi.org/10.1093/humupd/dmae001

• Wang, G., Liu, X., & Lei, J. (2023). Cognitive behavioural therapy for women with infertility: A systematic review and meta-analysis. Clinical Psychology & Psychotherapy, 30(1), 38–53. https://doi.org/10.1002/cpp.2792

• World Health Organization. (2025). Guideline for the prevention, diagnosis and treatment of infertility. https://www.who.int/publications/i/item/9789240115774